7[2]Henderson C,Berry DA,Demetri GD,et a1.Improved outcomes from adding sequential paelitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.J Clin Oncol,2003,21(6):976～983
8[3]Steven D Heys,Tarun Sarkar,Andrew W Hutcheon,et al. Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer.Expert Opinion on Pharmacotherapy, 2004,5(10):2147～2157
9[4]Citron ML,Berry DA,Cirrineione C,et a1.Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer:first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 974l.J Clin Oncol,2003,21(8):1431～1439
10[9]Early Breast Cancer Trialists'Collaborative Group.Tamoxifen for early breast cancer:an overview of the randomized trials.Lancet,1998,351:1451
